Previous Close | 280.56 |
1-Year Change | 47.25% |
6-Months Change | 44.98% |
3-Months Change | 7.63% |
Moving Avg (50d) | 271.77 |
Moving Avg (200d) | 226.68 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 19.6B |
Beta (3-Years) | 1.12 |
Revenue Growth (ttm) | 25.23% |
Net Profit Margin (ttm) | 7.71% |
Return On Assets (ttm) | 4.86% |
EPS (ttm) | 1.72 |
PE Ratio (ttm) | 163.12 |
Dividend Yield | % |
Asset Description: | Insulet Corporation |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-12-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
286.171 | 294.588 | 300.199 | 308.616 | 322.644 | 336.672 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |